Cargando…

A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa

INTRODUCTION: Warfarin is the most commonly prescribed oral anticoagulant in sub-Saharan Africa and requires ongoing monitoring. The burden of both infectious diseases and non-communicable diseases is high and medicines used to treat comorbidities may interact with warfarin. We describe service prov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Semakula, Jerome Roy, Mouton, Johannes P., Jorgensen, Andrea, Hutchinson, Claire, Allie, Shaazia, Semakula, Lynn, French, Neil, Lamorde, Mohammed, Toh, Cheng-Hock, Blockman, Marc, Sekaggya-Wiltshire, Christine, Waitt, Catriona, Pirmohamed, Munir, Cohen, Karen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988943/ https://www.ncbi.nlm.nih.gov/pubmed/31995565 http://dx.doi.org/10.1371/journal.pone.0227458

Ejemplares similares

A “Bundle of Care” to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study
por: Jorgensen, Andrea L, et al.
Publicado: (2023)

Improving anticoagulation in sub‐Saharan Africa: What are the challenges and how can we overcome them?
por: Mouton, Johannes P., et al.
Publicado: (2021)

A genome-wide association study of plasma concentrations of warfarin enantiomers and metabolites in sub-Saharan black-African patients
por: Asiimwe, Innocent G., et al.
Publicado: (2022)

Stable warfarin dose prediction in sub‐Saharan African patients: A machine‐learning approach and external validation of a clinical dose–initiation algorithm
por: Asiimwe, Innocent G., et al.
Publicado: (2021)

Direct oral anticoagulants versus warfarin: is new always better than the old?
por: Burn, John, et al.
Publicado: (2018)

Prevalence and factors associated with psychological distress among patients on warfarin at the Uganda Heart Institute, Mulago Hospital
por: Naisanga, Molly, et al.
Publicado: (2022)

A multi-factorial analysis of response to warfarin in a UK prospective cohort
por: Bourgeois, Stephane, et al.
Publicado: (2016)

Ethnic Diversity and Warfarin Pharmacogenomics
por: Asiimwe, Innocent G., et al.
Publicado: (2022)

A Review of A Priori Regression Models for Warfarin Maintenance Dose Prediction
por: Francis, Ben, et al.
Publicado: (2014)

Warfarin: better the devil you know
por: Blockman, Marc
Publicado: (2017)

Warfarin dosing algorithms: A systematic review
por: Asiimwe, Innocent G., et al.
Publicado: (2020)

Warfarin: The End or the End of One Size Fits All Therapy?
por: Pirmohamed, Munir
Publicado: (2018)

Impact of a mobile phone-based interactive voice response software on tuberculosis treatment outcomes in Uganda (CFL-TB): a protocol for a randomized controlled trial
por: Byonanebye, Dathan Mirembe, et al.
Publicado: (2021)

Safety and efficacy of hydroxychloroquine for treatment of non-severe COVID-19 among adults in Uganda: a randomized open label phase II clinical trial
por: Byakika-Kibwika, Pauline, et al.
Publicado: (2021)

Prenatal hepatitis B screening and associated factors in a high prevalence district of Lira, northern Uganda: a community based cross sectional study
por: Katamba, Paul Semakula, et al.
Publicado: (2019)

Community acceptability of dolutegravir-based HIV treatment in women: a qualitative study in South Africa and Uganda
por: Alhassan, Yussif, et al.
Publicado: (2020)

Low isoniazid and rifampicin concentrations in TB/HIV co-infected patients in Uganda
por: Sekaggya Wiltshire, Christine, et al.
Publicado: (2014)

Influence of CYP2C9 and VKORC1 on Patient Response to Warfarin: A Systematic Review and Meta-Analysis
por: Jorgensen, Andrea L., et al.
Publicado: (2012)

Comparative effectiveness of dabigatran, rivaroxaban, apixaban and warfarin in the management of patients with non-valvular atrial fibrillation
por: Pink, Joshua, et al.
Publicado: (2013)

“It’s only fatness, it doesn’t kill”: a qualitative study on perceptions of weight gain from use of dolutegravir-based regimens in women living with HIV in Uganda
por: Alhassan, Yussif, et al.
Publicado: (2022)

Incidence and predictors of COPD mortality in Uganda: A 2-year prospective cohort study
por: Alupo, Patricia, et al.
Publicado: (2021)

Monocyte unresponsiveness and impaired IL1β, TNFα and IL7 production are associated with a poor outcome in Malawian adults with pulmonary tuberculosis
por: Waitt, Catriona John, et al.
Publicado: (2015)

‘I fear my partner will abandon me’: the intersection of late initiation of antenatal care in pregnancy and poor ART adherence among women living with HIV in South Africa and Uganda
por: Alhassan, Yussif, et al.
Publicado: (2022)

Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study
por: Sekaggya-Wiltshire, Christine, et al.
Publicado: (2017)

Engendering health systems in response to national rollout of dolutegravir-based regimens among women of childbearing potential: a qualitative study with stakeholders in South Africa and Uganda
por: Alhassan, Yussif, et al.
Publicado: (2020)

‘Out of sight, out of mind?’ A follow-up on HIV-infected patients with drug-resistant pulmonary tuberculosis in Uganda: A case series
por: Notarfrancesco, Marco, et al.
Publicado: (2021)

A review of sustainable biodiesel production using biomass derived heterogeneous catalysts
por: Maroa, Semakula, et al.
Publicado: (2021)

Determinants of malaria infections among children in refugee settlements in Uganda during 2018–2019
por: Semakula, Henry Musoke, et al.
Publicado: (2023)

One-Year Survival and Prognosticators of Adults With Acute Leukemia at the Uganda Cancer Institute
por: Natukunda, Barbra, et al.
Publicado: (2023)

Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021)

Pharmacogenetics of warfarin in a paediatric population: Time in therapeutic range, initial and stable dosing, and adverse effects
por: Hawcutt, Daniel B, et al.
Publicado: (2014)

Prothrombin complex concentrates in warfarin anticoagulation reversal
por: Costa-Lima, Carolina, et al.
Publicado: (2012)

Graves' Disease and Treatment Effects on Warfarin Anticoagulation
por: Howard-Thompson, Amanda, et al.
Publicado: (2014)

Beyond warfarin: The advent of new oral anticoagulants
por: Laroia, Sandeep T, et al.
Publicado: (2015)

Beyond warfarin: The advent of new oral anticoagulants
por: Malhotra, Konark, et al.
Publicado: (2016)

Piperine Alters the Pharmacokinetics and Anticoagulation of Warfarin in Rats
por: Zayed, Aref, et al.
Publicado: (2020)

Quality of anticoagulation with warfarin in rural Chhattisgarh, India
por: Chebrolu, Puja, et al.
Publicado: (2020)

Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses
por: Pink, Joshua, et al.
Publicado: (2011)

Implementation of genotype-guided dosing of warfarin with point-of-care genetic testing in three UK clinics: a matched cohort study
por: Jorgensen, Andrea L., et al.
Publicado: (2019)

Risk factors for obstructed labour in Eastern Uganda: A case control study
por: Musaba, Milton W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kobscra9r7lmmnlbrfhbt4r1vl